Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 6268Carcinoma, Renal Cell 1913Urinary Bladder Neoplasms 1670Kidney Neoplasms 930Breast Neoplasms 793Neoplasms 788Carcinoma, Transitional Cell 594Carcinoma, Non-Small-Cell Lung 524Neoplasm Metastasis 510Melanoma 485Ovarian Neoplasms 468Colorectal Neoplasms 454Lung Neoplasms 435Pancreatic Neoplasms 325Testicular Neoplasms 290Stomach Neoplasms 274Sarcoma 267Uterine Cervical Neoplasms 264Non-Muscle Invasive Bladder Neoplasms 263Head and Neck Neoplasms 241Colonic Neoplasms 217Esophageal Neoplasms 203Squamous Cell Carcinoma of Head and Neck 202Carcinoma, Hepatocellular 197Wilms Tumor 196Endometrial Neoplasms 189Recurrence 162Neuroblastoma 148Urologic Neoplasms 147Small Cell Lung Carcinoma 146

Interventions

tislelizumab 1pamiparib 1TNFeraseBiologic 1Injections 1Gefitinib 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Locally Advanced Prostate Cancer × Genitourinary × Clear all
NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting
40 enrolled
Genitourinary

Locally Advanced Prostate Cancer

NCT01048151 2012-03-12

TNFerade Biologic to Treat Locally Advanced Prostate Cancer

GenVec

Phase 1 Unknown
20 enrolled
Genitourinary

Locally Advanced Prostate Cancer

NCT00319787 2011-01-25

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

AstraZeneca

Phase 2 Completed
102 enrolled
Genitourinary

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡